Podcasts about proscia

Today my guests are Dr Meriem Sefta, Chief Diagnostics Officer at Owkin, and Amanda Coble, Senior Director of Product at Proscia.  What we discuss with Amanda and Dr Sefta: The history of Owkin Founding vision and early challenges Deep learning in pathology Mission and Precision Oncology Digital pathology and AI integration Biomarker screening products like MSIntuit CRC Outcome prediction solutions like RLapseRisk BC Partnership with Proscia The future of pathology with AI Interoperability and collaboration Disclaimer: MSIntuit CRC, BRCAura BC, and RlapsRisk BC are under development and not for clinical use. They are not FDA cleared or approved in the USA. BRCAura BC and RlapsRisk BC are developed within the PortrAIt consortium, a french consortium financed by the government within the framework of France 2030 and by the European Union - Next Generation EU within the framework of the France Relance Plan. Owkin interoperability with Proscia's software is for Research Use Only. Not for use in diagnostic procedures. Links for this episode: The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients Owkin Proscia   People of Pathology Podcast: Twitter Instagram  

Polished is out. Grit is in. If you want your brand to cut through the noise, it might be time to take a cue from the underground music scene.In this episode, we're taking lessons from 90s indie rock with special guest Scott Rayburn, CMO of DataArt. Together, we talk about how brands can market with meaning, stay relevant in the digital age, and create content that hits like your favorite song.About our guest, Scott RayburnScott Rayburn is the Chief Marketing Officer at DataArt. He's experienced in leading cross-functional, high-performing content, GTM/sales, comms, operations, and creative teams, and skilled in content strategy, sales enablement, demand generation, SEO, product marketing, website strategy, branding, partner marketing, and providing creative direction.Scott has been with DataArt since 2023. Prior to his current role, he served as Director of GTM & Content at global technology services company Wizeline. He has also led product marketing at companies like The Risk Management Association and Proscia.What B2B Companies Can Learn From 90s Indie Rock:Lead with authenticity.
Great marketing doesn't have to be glossy, it just has to be real. The best indie rock bands of the '90s didn't rely on flashy production or major label backing to build loyal followings. They embraced raw sound, DIY, and intimate venues, and that resonated deeply with fans. Scott draws a parallel to modern marketing: “People can see through BS… you actually generally will get better results from the kind of authentic stuff.”Think in lifetimes, not just campaigns.
The strongest brands create lasting emotional connections, much like your favorite bands. “These bands that started in the eighties are still filling up 5,000-person theaters today,” Scott explains. Why? Because their fans feel a deep, emotional connection. For marketers, this means nurturing your audience beyond the funnel. Build a brand people want to grow old with, not just click on once.Stay active on every channel.
Indie rock bands don't just put out an album and disappear. Scott says, “Even if they're not making new songs, they need these channels to stay relevant, to sell tickets, to sell merch. It's all kinds of tied to marketing. And this is a tie between the authenticity and customer lifetime value. It's really activating that in a digital age.” Marketers need to do the same. A strong multi-channel strategy ensures your message reaches people where they are, whether that's a blog, a webinar, an event, or a TikTok feed. Being present across platforms consistently helps brands stay top of mind, accessible, and adaptable to change.Quotes*“ This authenticity that we were talking about with these bands, people can see through BS. Whether it's like an Instagram reel or a LinkedIn ad, or an email campaign. It can still work. Your marketing can still work if it's completely polished. But I think, and I see from some results that come from a company work that DataArt is doing. You actually generally will get better results from the kind of authentic stuff. And this is kind of where you see brand maybe driving more revenue than demand generation, but who can actually count the dollars from brand? Well, not me, but maybe someone can let me know. So those conversations are happening.”*“ These bands that started in the eighties are still filling up 5,000-person theaters today… There's this multi-channel approach, which is a huge part of marketing and content marketing. You notice they're all on Spotify. They all have websites, they all have social media. Even if they're not making new songs, they need these channels to stay relevant, to sell tickets, to sell merch, e-commerce. It's all kind of tied to marketing. And this is a tie between the authenticity and customer lifetime value. It's really activating that in a digital age.*“ The number one thing I've noticed in content marketing is the huge need to transition from the faceless 1000-word blog post to something that's more interactive. The quote with somebody's face on your social media post is gonna perform five times better than the faceless five AI trends.”*“ You can't do everything yourself. Build a good team around you. Be T-shaped 'cause you're not gonna be a marketing leader if you're not T-shaped…And try to create some way that you can stay focused on your strengths, and then lean on others who have strengths of their own. Have this kind of holistically built type of leadership team.”Time Stamps[0:55] Scott Rayburn, CMO at DataArt[02:02] Why 90s Indie Rock?[03:53] What is Record Store Day?[04:55] The Role of CMO at Data Art[06:38] Origins of 90s Indie Rock[10:50] The Indie Rock Movement and Its Impact[20:30] Building Community Through Music[31:11] B2B Marketing Takeaways from 90s Indie Rock[38:39] How You Can Be More Authentic in Your Marketing[46:55] Advice for marketing leaders[47:29] Final Thoughts and TakeawaysLinksConnect with Scott on LinkedInLearn more about DataArtAbout Remarkable!Remarkable! is created by the team at Caspian Studios, the premier B2B Podcast-as-a-Service company. Caspian creates both nonfiction and fiction series for B2B companies. If you want a fiction series check out our new offering - The Business Thriller - Hollywood style storytelling for B2B. Learn more at CaspianStudios.com. In today's episode, you heard from Ian Faison (CEO of Caspian Studios) and Meredith Gooderham (Head of Production). Remarkable was produced this week by Jess Avellino, mixed by Scott Goodrich, and our theme song is “Solomon” by FALAK. Create something remarkable. Rise above the noise.

Send us a textHow Can Digital Pathology Workflows Stay Compliant and Efficient?In this episode of the Digital Pathology Podcast, I sit down with Scott Randall, Senior Application Specialist at Hamamatsu (Hamamatsu NanoZoomer), and Amanda Coble, Senior Director of Product for Proscia (Proscia's Website), to discuss the critical role of compliance, interoperability, and efficiency in digital pathology workflows.

Today my guest is Jason Maloney, VP of Customer Experience at Proscia.  What we discuss with Jason: His background in customer-facing roles across various company sizes. Being drawn to Proscia by the opportunity to impact lives through digital pathology. Customer Experience (CX) encompasses professional services, technical support, and customer success, focusing on the post-sale experience. Many companies in the industry focus on product development without adequately addressing customer needs and experiences. Jason applies insights from various industries, emphasizing the importance of treating customers as humans and understanding their workflows. Proscia's CX strategies have led to reduced time to go live with software and improved overall customer satisfaction. Proscia fosters a continuous feedback loop between customers and internal teams, enhancing product development and customer support. Proscia's CX team helps pathologists and researchers integrate AI into their workflows, providing expertise and support. The future focus will be on developing trusted advisor relationships with customers, enhancing customer success initiatives, and deepening problem-solving capabilities.   Links for this episode: Pathologists' Assistant Shadowing Network on LinkedIn Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Proscia Expanded Customer Experience (CX) Practice Enables Users To Realize Value Over 30% Faster   People of Pathology Podcast: Twitter Instagram

Join us for a PRessing On in Public Relations conversation with Amanda Proscia, Co-founder from Lightspeed Public Relations and Marketing, a New York City-based agency focused on the technology sector. Listen in as we dig deep into unlocking the secrets to creating a powerful public image. An unexpected part of her experience over the years has been fielding thousands of questions about public relations. Many of them come from business leaders who would benefit from a PR program of their own, if they just understood what it is. Amanda's writing has been published in many top-tier publications, but—true to her profession—always under someone else's name. She has served as a ghostwriter for Fortune 50 executives, prominent politicians, and countless client leaders, helping to amplify their voices from behind the scenes. With her new book, PR Confidential, she's stepping out of the shadows to make her insider's knowledge available to everyone.    To connect with Amanda, track her down at: LightSpeedPR.com https://www.linkedin.com/in/amandacproscia/ https://www.linkedin.com/company/lightspeed-pr/ ------------------------------------------------------------------ For more information visit ⁠⁠⁠PressingOnPodcast.com⁠ RMGComm.com DeGravePR.com  

Tara "Blitzy" Blitzer Benson '93 brings her signature humor, sharp insights, and favorite Cornell memories to the podcast! From her days as an enthusiastic social chair to her impressive career as Vice President and General Counsel at Proscia, a cutting-edge digital pathology company, Tara's story is as inspiring as it is fun. She raised two Cornellians, one starting next fall, and she shares her unique perspective as both an alum and a parent. Oh, and as a college town bartender.Get ready for sage advice for Cornell parents and tales of Slope Days, Santas, and life with incredible Cornell connections!LinkedIn: Tara Blitzer BensonNot sponsored by or affiliated with Cornell University

Julianna Ianni from Proscia joins me today. What we discuss with Julianna: Her background in biomedical engineering and biomedical imaging. Transition from radiology to pathology and the overlap between the two fields. Role as VP of AI Research and Development at Proscia, focusing on AI applications in digital pathology. An overview of foundation models Embeddings and their role in feature extraction from data Concentriq Embeddings by Proscia: The importance of data diversity in training AI models Importance of collaboration with other companies in developing AI solutions. Future possibilities for foundation models in pathology, including multimodal applications. Links for this episode: Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Concentriq Embeddings Overview "How Proscia's AI R&D Team Leveraged Foundation Models at Scale to Build 80 Breast Cancer Biomarker Prediction Models in Under 24 Hours" Foundation Models For Pathology AI Development At Your Fingertips Accelerating Tumor Segmentation Model Development with Concentriq Embeddings The Hidden Costs of AI Development in Pathology and How Concentriq Embeddings Helps Life Sciences Organizations Mitigate Them   People of Pathology Podcast: Twitter Instagram

Nathan Buchbinder from Proscia returns to discuss Proscia's Precision Medicine AI Portfolio. The portfolio includes leading AI applications available on the Concentriq platform. The portfolio streamlines the process of deploying, supporting, and using AI applications in pathology. The portfolio includes applications from Proscia and other developers, including Ibex, Visiopharm, Stratipath, DoMore Diagnostics, Mindpeak, Nucleai. Collaboration with other vendors and developers is important to address the variety of AI applications needed and helps streamline the process. Multi-AI workflows on Concentriq enable the simultaneous use of multiple AI applications on a single image or work list. The Precision Medicine AI portfolio supports analysis of various tissue types, with a growing portfolio. The partnership with Nucleai enhances the functionality of Concentriq by incorporating AI biomarkers. Proscia's is focused on expanding the Precision Medicine AI portfolio, making platform enhancements, and adding new functionality. Proscia is not the legal manufacturer of the products available in its precision medicine AI portfolio and pipeline. Certain products may only be available for diagnostic use in select geographies. Please contact Proscia for availability of an application in your geography. Multi-AI workflows are available on Concentriq AP. Concentriq AP is for research use only. Not for use in diagnostic procedures.   Links for this episode: Labvine Laboratory Transformation Seasonal School Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Concentriq AP: A New Era of AI in Pathology Webinar   People of Pathology Podcast: Twitter Instagram

Gayathri Radhakrishnan, partner at Hitachi Ventures, shares profound insights from her journey and perspectives on venture capital and technology. Gayathri reflects on her early life in India and how her competitive spirit and supportive family shaped her path to challenging norms in male-dominated fields. She delves into her focus on impactful investments in AI, utilizing Hitachi Ventures' corporate strengths to strategically nurture startups. Gayathri values founder passion, problem understanding, and openness to feedback, and her advice to founders stresses preparation, boldness, and leveraging networks for lasting partnerships and growth.In this episode, you'll learn:[1:54] The making of Gayathri Radhakrishnan: Challenging norms and building a strong sense of confidence and competitiveness.[10:32] The responsibility and impact that venture capital has on shaping future generations[14:10] Impact of corporate venture capital, when done right: Hitachi Ventures' commitment to patient capital with a 10-year fund cycle further underscores their long-term support for startups.[18:21] Trends and opportunities: Entrepreneurs should explore opportunities where AI can revolutionize industrial processes, enhance safety and efficiency, and contribute to sustainable practices.[23:37] Passionately understand your problem, stay open to feedback, and ensure your solution has real-world validation and market potential.[28:20] Aim for follow-up meetings and leverage the investor's network for potential introductions. [35:15] What's the immediate threat posed by AI?The non-profit organizations that Gayathri is passionate about: SV2About Gayathri RadhakrishnanGayathri Radhakrishnan is currently Partner at Hitachi Ventures, focusing on AI investments in Manufacturing, Healthcare, and Automotive. With over 20 years in technology, she has held roles at Dell, Corning, and Micron Ventures, and served as a Partner at Earlybird Venture Capital. Gayathri holds an MS in EE from The Ohio State University, an MBA from INSEAD, and is a Kauffman Fellow. She has driven strategy at Dell's Software Group and mentored startups at TechRanch Austin and Techstars Cloud.About Hitachi VenturesHitachi Ventures is the global venture capital arm of Hitachi Group. Hitachi Ventures invests in innovative companies that address society's key technological challenges in areas like IT, industrial automation (robotics, sensor technology and IoT), cloud services (data management, cybersecurity), mobility (autonomous driving, mobility services, smart infrastructure and security services), energy, smart medicine (AIfor digital imaging, smart diagnostics, remote care), smart city, smart infrastructure and more. It's portfolio includes companies such as Samsara Eco, Trustwise AI, WEKA, StrikeReady, Archetype AI, WASE, Cure51, Proscia, Thea Energy, Captura among others.Subscribe to our podcast and stay tuned for our next episode.

David West, co-founder and CEO of Proscia, shares his journey from student/researcher to founding and building a medical software company whose goal is to improve cancer diagnosis through technology.We discussed how he developed his vision of authentic leadership while building the company as he transitioned from a scientist/hands-on entrepreneur to a leader who fosters a problem-solving mindset within his team. He shared the importance of finding the right investors and how transparency and effective communication are key in building trust with the venture capitalists on the board of directors.Contact Dino at: dino@al4ep.comWebsites:Proscia.comal4ep.comAdditional Guest Links:David WestLinkedIn: linkedin.com/in/david-r-westTwitter / X: @davidwest_irl ProsciaLinkedIn: linkedin.com/company/prosciaTwitter / X: @ProsciaAuthentic Leadership For Everyday People / Dino CattaneoDino on LinkedIn: linkedin.com/in/dinocattaneoPodcast Instagram – @al4edp Podcast Twitter – @al4edp Podcast Facebook: facebook.com/al4edpMusicSusan Cattaneo: susancattaneo.bandcamp.comThis podcast uses the following third-party services for analysis: Chartable - https://chartable.com/privacy

My guests today are Imogen Fitt from Signify Research and Nathan Buchbinder from Proscia.  We discuss emerging trends in pathology, including: The current technology with the most significant impact in the field of pathology has been artificial intelligence (AI). AI has stirred up imaginations about the future of pathology and has accelerated the timeline for seeing its impact. Return on investment in digital pathology has shifted from being a challenge to becoming an opportunity that drives adoption. Pathologists are not being replaced by AI but rather augmented by it to make their work easier and more efficient. Precision medicine is a key emerging trend in pathology, with a focus on clinical biomarkers, companion diagnostics, and personalized treatment pathways. Telepathology plays a crucial role in improving access to pathology services, especially in underserved areas and remote locations. Collaboration among digital pathology companies is driven by customer demand for interoperability and seamless integration of technologies. The future of pathology technology is likely to focus on precision medicine, clinical biomarkers, companion diagnostics, digital pathology storage, compression algorithms, robotics, and value-based care.   Links for this episode: Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Signify Research Proscia   People of Pathology Podcast: Twitter Instagram

Is your agency news newsworthy? How interesting, immersive, compelling, and targeted is your news to give you results? Making your agency newsworthy takes expertise and an understanding of what works for you and your goals. In this episode of The Agency Blueprint, I'm joined by Amanda Proscia & Mickie Kennedy to discuss PR and how to make your press releases newsworthy. Amanda is the co-founder of Lightspeed Public Relations and Marketing, a New York City-based agency focused on promoting innovation in areas like healthcare, financial services, and consumer electronics. Mickie is the founder of eReleases, a press release distribution service for startups & small businesses. He founded eReleases 24 years ago to help small businesses, authors, and startups increase visibility and credibility through press release marketing. Don't miss this episode to learn the importance of having a target audience, why you should be well-prepared before inviting PR, and more. Key Questions: [02:13] How do you know whether the news your agency plans to release is newsworthy? [07:50] What can be done in preparation for a press release and after? [10:53] Mickie, can you walk us through the trends and types of things that are working right now that didn't work before and things that were working before but aren't working right now? [16:00] When should an agency consider the timing considerations for both PR and some earned media? [21:16] How can creativity come into PR and press releases in a way that allows for a little engagement with the journalists? What You'll Discover: [02:27] Amanda explains the expertise required to find opportunities that make agency news newsworthy. [04:05] How to target a specific audience and accomplish your goals by being at the right place with the right story. [05:24] How to make PR relevant to the media, taking into account what their audience would find interesting. [08:05] Questions to ask and strategies to apply before a press release and the pitching to do afterward. [11:21] The power of authenticity and owning your story in PR and why they worked before and in modern times. [16:19] Why you should be well prepared before considering it time to invite media attention to your agency. [18:49] The evolution of media recently and why it hasn't changed the value of newswires and PR professionals. [21:46] Creativity and tech tools to use to tell stories in the most immersive and compelling ways. [23:51] Mickie and Amanda share tips on where to start with PR as an agency considering PR. Connect with Amanda& Mickie: Amanda's LinkedInAmanda's Website & BookMickie's Website

Ray Proscia dropped by the pod to talk about playing Dr. Lipschitz on the hit TV show Suits. Ray also talked about auditioning for the show, meeting Rick Hoffman (Louis Litt) for the first time, his emotional scene with Gabriel Macht (Harvey Specter), the show ending, the new Suits LA, and so much more!

Amanda Proscia is the Chief Operating Officer and Co-Founder of Lightspeed Public Relations/Marketing. Here, we discuss her new book, “PR Confidential: Unlocking the Secrets to Creating a Powerful Public Image.” The book provides an insider perspective on getting the most out of an investment in a public relations agency. It also provides great insights on how PR works, when it fails, and how to course-correct as the story changes. Key Takeaways:- Answers to common questions about PR- The "3 I" formula- Why do we need to keep making the case for PR?Episode Timeline:1:30 What inspired Amanda to write "PR Confidential"?3:15 Are tech people open to learning about PR?4:15 The difference between PR and advertising?5:15 PR is more than writing press releases6:15 The "3 I" formula for newsworthiness7:30 What is good thought leadership?10:00 Why do we have to keep selling the idea of PR?13:45 Why "PR Confidential" is written like an advice column15:00 The "confidential" parts of Amanda's book16:24 The PR elevator pitch 18:00 "PR Confidential Part 2: The sequel"This episode's guest:• Amanda Proscia on LinkedIn• Download "PR Confidential" for free at Lightspeed PR and MarketingSubscribe and leave a 5-star review: https://pod.link/1496390646Contact Us!• Join the conversation by leaving a comment!• Follow us on Facebook, Twitter, Instagram, and LinkedIn!Thanks for listening! Hosted on Acast. See acast.com/privacy for more information.

This week, the digital pathology community gathered at the United States and Canadian Academy of Pathology (USCAP) annual meeting in Baltimore. I had the incredible opportunity to attend, spurred by an invitation from Hamamatsu, known for their revolutionary digital pathology scanners like the FDA-cleared S360 and the new S20 model.Key Takeaways from USCAP:Innovative Partnerships and Technology: My agenda was filled with meetings that explored the latest in digital pathology. Key highlights include the launch of Hamamatsu's S20 scanner, Techcyte's technological advancements, and Proscia's FDA-approved AP Dx software. The collaboration between Hamamatsu and Agilent, utilizing Proscia's platform, underscored the collaborative spirit driving the field forward.Community Engagement and Recognition: The warmth and recognition from the community were overwhelming. It reinforced the value of our work and the podcast, blending technical insights with personal stories that underline the human aspect of pathology.Advancing Research and Education: A standout moment was learning about the World Tumor Registry initiative from Andrey Bychkov and Alyaksandr Nikitski. This initiative marks a significant step in making valuable pathological data more accessible for research and education, starting with a comprehensive collection of thyroid case slides.Looking Forward:The USCAP meeting was a testament to the enthusiasm and innovation within digital pathology. Stay tuned for a detailed video blog covering the conference, highlighting the S20 and more, coming soon on YouTube!USCAP BULLET UPDATESHamamatsu: Known for their FDA-cleared scanner, S360, and the newly launched S20 model.Techcyte: Discussed their dynamic evolution and upcoming projects and their partnership with BD for cervical cytology AI based evaluation.Corista: Learned about their software advancements, including voice recognition for improving pathologist workflows.Smart In Media: Discussed their new camera for microscopes and grossing rooms.Proscia: Celebrated their FDA clearance for the AP Dx software.Epredia: Showcased their pathology equipment, including scanners like the P1000 with water immersion.Aiforia: Highlighted their AI for image analysis, especially the GLP-compliant module for toxicologic pathology.Indica Labs: Featured their pathologist cockpit setup and discussed their comprehensive software solutions.PathPresenter: Met with the CEO, Patrick Myles, and discussed the company's rapid growth and services.Pramana: Discussed their archival scanning services and their new benchtop scanner that runs algorithms during scanning.Grundium: Showed off their new four-slide scanning Ocus and the cute one-slide Ocus scanner. Andrej Bychkov to discuss his poster on the use of ChatGPT by pathologists and told me about the World Tumor Registry initiative.Support the showBecome a Digital Pathology Trailblazer and See you inside the club: Digital Pathology Club Membership

In this episode, David West discusses Proscia's recent 510K clearance for Concentric AP-DX software. The conversation delves into the significance of 510 k clearance, explaining its role in regulatory approval for medical devices. David highlights the company's global success and previous clearances in Europe, offering insights into the journey of bringing innovative software to laboratories worldwide. We discuss not only the importance of this clearance to Proscia, but also to digital pathology as a whole.     Links for this episode: Proscia Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx Welcome To Concentriq AP-DX Webinar   Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club     People of Pathology Podcast: Twitter Instagram

In this episode, we delve into how Proscia's recent $46 million Series C funding round is setting the stage for AI-driven pathology to become a mainstream tool in healthcare. We'll explore the implications of this significant investment for the future of pathology and patient care. Get on the AI Box Waitlist: ⁠⁠⁠⁠⁠⁠https://AIBox.ai/⁠⁠⁠⁠⁠⁠ Facebook Community: ⁠⁠⁠⁠⁠https://www.facebook.com/groups/739308654562189⁠⁠⁠⁠ Follow me on X: ⁠⁠⁠⁠⁠⁠https://twitter.com/jaeden_ai

Jeff Rhude is the VP of Technical Operations at Proscia.  Today we discuss the use of cloud-based technologies in digital pathology. Cloud-based storage offers significant advantages over traditional on-premises solutions in the field of digital pathology. The episode highlights several key benefits that make cloud storage a compelling choice for storing sensitive patient data and large image files in pathology. Cloud-based storage offers superior data durability, security, and recovery capabilities.  It also allows for access to the latest AI capabilities.   AI technologies, such as ChatGPT, have already shown significant improvements in various industries, including healthcare. With cloud computing, Pathologists can leverage AI tools to enhance their diagnostic capabilities, streamline workflows, and improve patient outcomes. However, resistance to technology can lead to being left behind in a rapidly advancing field.  So it is important to embrace technology to keep up with the rapidly changing pathology field.    Links for this episode: Pathology 101 for Tissue Image Analysis  Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Proscia Website Cloud technologies in digital pathology: taking pathology to the cloud from Pathology News   People of Pathology Podcast: Twitter Instagram

In this episode, we dive into the heart of digital pathology's evolution with David West, CEO of Proscia, a company at the forefront of transforming pathology into a data-driven discipline. Proscia has recently made headlines with its FDA 510(k) clearance for Concentriq AP-Dx, marking a significant milestone in harnessing AI for enhanced diagnostic accuracy. Join us as we explore how Proscia's Concentriq® platform and its suite of AI applications are pioneering the shift towards precision medicine, promising to improve patient outcomes, accelerate research, and overcome the challenges of modern pathology. From the inception of Proscia at Johns Hopkins University to becoming a global leader with its innovative solutions, learn how they're not just adapting to the future—they're creating it. Discover the vision, technology, and passion behind Proscia's mission to perfect cancer diagnosis and what this means for the future of healthcare.

SummaryIn this episode, Mitch Robbins interviews Melanie Leibovitz, a regulatory and quality executive with over 25 years of experience in the medical device and digital health sectors. Melanie shares her journey from growing up in New Jersey to falling into the regulatory and quality field. She emphasizes the importance of soft skills for executive roles and offers advice on developing these skills. Melanie also discusses the role of AI in regulatory and quality and encourages professionals in the field to adapt and learn new skills. She concludes by sharing her hope of leaving a legacy in the industry.TakeawaysSoft skills, such as communication and problem-solving, are crucial for regulatory and quality professionals to excel in executive roles.Building a strong network and finding mentors who can provide guidance and support is essential for career growth.AI has the potential to enhance regulatory intelligence and make the work of regulatory professionals more efficient.Regulatory and quality professionals should embrace challenges and persevere in order to make a difference in the industry.Tune in for this and so much more!

David West is a computational biologist, entrepreneur, and co-founder of Proscia. Proscia is a company advancing data-driven pathology with its Concentriq platform and computational solutions. David joins this episode live from Orlando to discuss how the digital pathology market has changed in the last 5 years. Next, he shares insight on scaling up and hiring in digital pathology. Finally, David speculates what the next wave of innovations will bring to pathology.A forum to engage with the hosts and other listeners has been launched on the DPA website www.digitalpathologyassociation.org. DPA members may login to the DPA Collaborate hub (under the Resources tab) and join the Beyond The Scope community. All listeners are encouraged to use this forum to suggest future topics and guests, submit questions and corrections, and provide general feedback.

How can we break down dev team silos for increased communication and a better-quality end product? Reversing Conway's Law is one way to go about it, and today's guest has a wealth of experience on how to do just that! Krishna Bala is the Senior VP of Engineering at Proscia, a medical imaging startup that is fighting cancer with AI-enabled Digital Pathology. Using the case study of Proscia itself, Krishna outlines the benefits of building common elements across teams and handling change management when reorganizing roles and teams.There is also an in-depth explanation of Conway's Law as well, for those tech companies looking to break down the barriers to better communication between their teams and not be limited in their output by their organizational structure. Higher quality product by design awaits. We just have to reverse a law to do it. Krishna's knowledge of how to build your organization to achieve its goals will surely be appreciated. Please join us."As humans, I think we're just comfortable staying in that hierarchy, staying in our own little system. Work is hard enough, challenging enough that you basically say, 'Okay, this is my box; I'm going to innovate within that box'." ~ Krishna BalaIn This Episode:- Why are silos bad? - What is Conway's Law?- Reversing Conway's Law: what does that entail?- What good comes from breaking down siloes?- How is Krishna using this thinking in his work today?- Organizing a deliberate common core team - Changing the tires while the car is moving!- Appreciating the importance of change management- Figuring out the release cadence for your common core teamAnd more!Connect with Krishna Bala:- LinkedIn - https://www.linkedin.com/in/kbala97/- Website - https://proscia.com/Connect with Debbie Madden:- Website - https://www.stride.build/- LinkedIn - https://www.linkedin.com/in/debbiemadden1/- LinkedIn Page - https://www.linkedin.com/company/stride-build/

Digitization and AI are transforming pathology by accelerating research and modernizing the clinical workflow. Proscia co-founder and CEO David West's entrepreneurial journey --and experience with digitization and handling personal information-- began with a business converting VHS tapes to disc.  We explore David's multidisciplinary approach, combining software, biology, and physics, which led to the creation of Proscia and its flagship platform, Concentriq. This conversation traces his path from academic research at Johns Hopkins University to becoming a key figure in medical technology innovation, highlighting the transition of pathology from traditional methods to digital solutions.The discussion includes an examination of digital pathology's impact on the medical field, emphasizing how Proscia's cloud-based system enhances data management and algorithm development capabilities for pathologists. We also address the broader implications of integrating AI into pathology, including challenges related to healthcare reimbursement and the potential for AI to revolutionize laboratory economics and patient care.Lastly, David  provides insights into the future of AI in life sciences and healthcare, predicting its role in biomarker discovery and therapy recommendations.He concludes by recommending the book, The Fish That Ate the Whale --about the Banana King, Samuel Zemurray.Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

David West (Co-Founder & CEO, Proscia) discusses how his company uses AI to accelerate breakthroughs in pathology.

In this episode, I am joined by Amanda Proscia, co-founder of Lightspeed Public Relations and Marketing. Amanda emphasizes that business owners should not feel intimidated by PR. She encourages them to explore how PR can benefit their business and enhance its success and visibility. Amanda acknowledges that even if business owners are unfamiliar with PR, there are ways they can leverage it to their advantage. She suggests that her book, "PR Confidential, Unlocking the Secrets to Creating a Powerful Public Image," could be valuable for understanding PR and its potential benefits. Ultimately, Amanda's message is that PR offers valuable business opportunities, and it is worth exploring how it can be utilized effectively. Show notes:  [00:01:40] Writing in PR. [00:03:49] Earned media in public relations. [00:09:26] Different components of PR. [00:12:08] Repurposing information on social media. [00:16:06] Overly rehearsed speeches. [00:19:40] Insight in musculoskeletal care. [00:24:09] The role of technology. [00:26:22] Press release distribution services. [00:31:09] Don't be intimidated by PR.More About Amanda: Amanda Proscia is the co-founder of Lightspeed Public Relations and Marketing. Before founding Lightspeed, Amanda worked in a variety of other agencies and businesses, spanning from the very large ones to the very small. An unexpected part of her experience has been fielding thousands of questions about public relations. Many of them come from business leaders who would benefit from a PR program of their own, if they just understood what it is. Resources from this Episode:  Website Amanda's LinkedIn Amanda's book: PR Confidential, Unlocking the Secrets to Creating a Powerful Public Image Follow Dr. Karen Litzy on Social Media: Karen's Twitter Karen's Instagram Karen's LinkedIn Subscribe to Healthy, Wealthy & Smart: YouTube Website Apple Podcast Spotify SoundCloud Stitcher iHeart Radio 

Amanda Proscia is the co-founder of Lightspeed Public Relations an Marketing AND best selling author of PR Confidential. Enjoy hearing Amanda talk about the importance of telling the right story to attract the right outcomes, 5 tips for unlocking your company story, and examples of right strategy and right story. Hear host Rick Tocquigny and Amanda dissect the recent Amazon ad with three old women who sled down the hill.Become a supporter of this podcast: https://www.spreaker.com/podcast/success-made-to-last-legends--4302039/support.

Amanda Proscia is the co-founder of Lightspeed Public Relations an Marketing AND best selling author of PR Confidential. Enjoy hearing Amanda talk about the importance of telling the right story to attract the right outcomes, 5 tips for unlocking your company story, and examples of right strategy and right story. Hear host Rick Tocquigny and Amanda dissect the recent Amazon ad with three old women who sled down the hill.

Amanda Proscia, co-founder of Lightspeed Public Relations and Marketing, is the author of PR Confidential, available now. Lightspeed is a New York City-based agency focused on promoting innovation in areas like healthcare, financial services, and consumer electronics. We discussed all of this and more this week on the On Brand podcast. About Amanda Proscia Amanda Proscia is a master corporate storyteller with experience in-house at American Express. Amanda is the co-founder of Lightspeed Public Relations and Marketing, a New York City-based agency focused on promoting innovation in areas like healthcare, financial services, and consumer electronics. She's also the author of the bestselling new book, PR Confidential.  Links from the Show On Brand Soundbite. "In addition to the millions of dollars wasted on ads that are not digitally optimized, brands are missing other marketing opportunities for their holiday promotions,"  says Amanda Proscia. "Each holiday season, ads are repeated from previous years without any updating to their message or target audience. Not only does this result in ads that under-perform, but it also misses out on gaining the value of refreshed storytelling." What brand has made Amanda smile recently? “Oreo — and not just because I love their cookies.” Amanda shared that her smile came from their recent cookie ad featuring a diverse Santa Claus. Connect with Amanda on LinkedIn and the Lightspeed PR website. As We Wrap … Listen and subscribe at  Apple Podcasts, Spotify, Amazon/Audible, Google Play, Stitcher, TuneIn, iHeart, YouTube, and RSS. Rate and review the show—If you like what you're hearing, be sure to head over to Apple Podcasts and click the 5-star button to rate the show. And, if you have a few extra seconds, write a couple of sentences and submit a review to help others find the show. Did you hear something you liked on this episode or another? Do you have a question you'd like our guests to answer? Let me know on Twitter using the hashtag #OnBrandPodcast and you may just hear your thoughts here on the show. On Brand is a part of the Marketing Podcast Network. Until next week, I'll see you on the Internet! Learn more about your ad choices. Visit megaphone.fm/adchoices

Amanda Coble is a pathologists' assistant with a diverse career path. After completing her education, she worked as a pathologists' assistant and also took on management activities, such as designing a new anatomic pathology laboratory space and participating in the selection and implementation of a new laboratory information system (LIS). Her experience in managing the LIS led her to explore a career in product management, gaining experience in understanding customer needs, working with software engineering teams, and rolling out new products. In 2021, Amanda joined Proscia and is now the Director of Product Management.  Amanda believes that better collaboration between the clinical and industry parties is crucial for advancing digital pathology. This includes sharing real-world data for AI development, improving interoperability between systems, and working towards standardization, such as the use of DICOM format. She sees AI playing a significant role in triaging workflow, automating routine tasks, and unlocking new insights and functionality in pathology.   Links for this episode: Pathology 101 for Tissue Image Analysis  Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Learn More About Proscia    People of Pathology Podcast: Twitter Instagram

Today, we're sitting down with Amanda Proscia, co-founder of Lightspeed Public Relations and Marketing! Lightspeed Public Relations and Marketing is a New York City-based agency focused on promoting innovation in areas like healthcare, financial services, and consumer electronics. Before starting Lightspeed in 2013, Amanda worked in various other agencies and businesses, spanning from the very large to the very small. An unexpected part of her experience has been fielding thousands of questions about public relations. Many of them come from business leaders who would benefit from a PR program of their own… if they just understood what PR is! She is also the author of PR Confidential: Unlocking the Secrets to Creating a Powerful Public Image. To learn more about Amanda, check out her website: https://lightspeedpr.com/ * * * Join our free Facebook group community: https://www.facebook.com/groups/profitableprpros/ Download our free resources: https://www.jenerationacademy.com/our-resources Become a Pitching Powerhouse: https://www.jenerationacademy.com/programs See our success stories: https://www.jenerationacademy.com/pr-pro-spotlight Access our online hub for PR pros: https://www.profitableprpros.com

Innovative companies must convince buyers and analysts why their solutions differ from the status quo, and why that difference matters. But sometimes, developing the right narrative can be a challenge. This is where a well-crafted point of view (POV) can help. In this episode, we're joined by David West, co-founder and CEO of Proscia. After attending a category design workshop, David was finally able to get the market to understand why his company's solution in pathology was such an important breakthrough. Listen now to learn:Why category design helped David's company set itself apart from commoditized products in his industryHow Proscia gained analyst support by telling their customers the story they hoped to hearWhy having conviction in your point of view is so crucial in conditioning the market to think differentlyThis episode was hosted by John Rougeux and Mike “Damp” Damphousse.‍This episode is sponsored by:Category Design AdvisorsBeTheStage.live

Jacki and Lyle are joined this week by the brilliant Amanda Proscia. Amanda is the COO and Founder of Lightspeed Marketing & PR, a New York City-based agency focused on promoting innovation in areas like healthcare, financial services and consumer electronics. Before starting Lightspeed in 2013, she worked in a variety of other agencies and businesses, including American Express, Burson-Marsteller, and Interbrand. Her incredible level of experience and expertise in the industry has, perhaps understandably, led to Amanda fielding thousands of questions about public relations throughout your career. Amanda is also the published author of PR Confidential: Unlocking the Secrets to Creating a Powerful Public Image, a brilliantly entertaining and insightful look at exactly what PR is. In an incredibly informative episode, Amanda outlines why she decided to write the book, and why structuring it in a 'Dear Abby' style was crucial to making the book the book as educational and fun for professionals as possible. Amanda and Jacki both agree that often the problem for businesses is that they don't understand fully what PR is, while Lyle goes further and argues that by the time they know what it is, they're not altogether ready to engage with the PRs themselves! Amanda finishes the episode by telling you where you can access PR Confidential, including where you can get it for free on the Lightspeed PR website, before Lyle offers up his services for the audiobook which will be released early next year!For access to a free download of PR Confidential, and for more more about Lightspeed PR, head to: https://lightspeedpr.com/Artwork by Daff KjellströmMusic by Lyle FultonGet in touch via lyle@dimoso.com or info@dimoso.comMore information at www.dimoso.com and www.therestispr.comFollow us on Twitter - @TheRestIsPR Hosted on Acast. See acast.com/privacy for more information.

Casey Wahl is Senior Product Manager for Core Platform and AI at Proscia. She has been working in the digital pathology space since 2019. We discuss the innovation boom happening in pathology and the benefits of going digital. Casey talks about the increasing importance of artificial intelligence in pathology, as it enables faster analysis and new workflows for precision medicine.  This episode highlights the intersection of technology and healthcare, showcasing the potential of digital pathology to improve access to care and have a profound impact on patients' lives.   Links for this episode: Pathology 101 for Tissue Image Analysis  Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Proscia Automated QC The Significance of Robust Validation in Automated Quality Control Solutions   People of Pathology Podcast: Twitter Instagram

Building a career is a series of choices, outcomes of those choices, and then reacting to those outcomes. Sometimes a small choice can have an outsized return, sometimes the reaction to an outcome can lead you down a new path. In investing we are looking for power-law returns, the small bets that we can return exponential value.Our guest today is an investor who has seen some amazing choices turn into huge returns and even better stories to teach and entertain us. Alexander Niehenke is a Partner at Scale Venture Partners where he specializes in Vertical SaaS investing.And John Ruffolo is back to talk about the news!About Alexander Neihenke:Alex Neihenke is a Partner at Scale Venture Partners since 2017. He has focused on early investments in vertical software markets where incumbents have failed to invest in advanced technology offerings. That thesis has led to investments in Archipelago, Dusty Robotics, Motive formally KeepTruckin, Root Insurance, Scout RFP, Spruce, Proscia, and Proxy. Motive has been one of the fastest growing SaaS companies of all time; Scout RFP was acquired by Workday in late 2019 for $540M; and Root completed its IPO in late 2020.He received his bachelor's from UC Berkeley.In this episode we discuss:(0:00:56) News rundown with John Ruffolo(0:16:27) Alexander's path to becoming an investor(0:18:45) The effect of watching his dad work so hard(0:20:50) Alex's experience working in the banking industry(0:24:31) How the experience at Crosslink Capital shaped his career(0:25:56) His role advising Dollar Shave Club(0:28:08) On investing in friends(0:29:46) Joining Scale Venture Partners in 2013(0:32:17) How he focused on Vertical SaaS(0:35:23) Alex's definition of Vertical SaaS(0:36:20) Misconceptions around Vertical SaaS(0:38:11) Why there's a misunderstanding around TAM(0:40:08) Case studies around misaligned TAM(0:44:04) Lessons from his investment in Root Insurance(0:48:59) How Scale's outlook has evolved over the last few years(0:52:06) Why Alex invested in Ripple Portfolio company Rose Rocket(0:54:30) Rules he lives by when joining a new board(0:57:29) What makes a good board member(1:00:00) Why Alex writes about industries prior to investing in them(1:02:52) Thoughts on the AI investing craze(1:05:47) Using data to analyze massive volumes of startups and their success(1:09:16) What would he be doing if he wasn't an investorFast Favorites:*

In this episode of Clinical Lab Chat, Chris Wolski, CLP's director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today, including workforce shortages, scaling lab operations, and reimbursement, along with some of their solutions, including increased automation, agnostic platforms, and more coherent reimbursement coordination with regulatory agencies.

In this episode of Clinical Lab Chat, Chris Wolski, CLP's director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today, including workforce shortages, scaling lab operations, and reimbursement, along with some of their solutions, including increased automation, agnostic platforms, and more coherent reimbursement coordination with regulatory agencies.

Victoria Proscia, Stylist and Image Consultant at House of Colour Charlottesville, Katie Cox, Local Digital Content Creator at Supporting Local Cville, and Matthias John of Matthias John Realty joined Michael Urpí & Nickolas Urpí On “Today y Mañana!” “Today y Mañana” airs every Thursday at 10:15 am on The I Love CVille Network! “Today y Mañana” is presented by Emergent Financial Services, LLC, Craddock Insurance Services Inc, Castle Hill Cider and Charlottesville Opera, with Forward Adelante.

Today my guest is Pathologist Dr Derek Welch  What we discuss with Dr Welch: Why he chose medical school and how he discovered pathology How he joined PathGroup and his current role as Chief Medical Officer The collaboration between PathGroup and Proscia His thoughts on the future of artificial intelligence in pathology How pathology data can be used in precision medicine and why pathologists should be part of this Links for this episode: Pathology 101 for Tissue Image Analysis  Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   PathGroup Proscia PathGroup Chooses Proscia to Deliver Next Generation of Cancer Diagnosis for Millions of Patients   People of Pathology Podcast: Twitter Instagram

 This time around on the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Nathan Buchbinder, cofounder and chief product officer at Proscia about pathology data, why it has taken so long to digitise it, and what the possibilities are when this data is freed from its historical siloes. 

There is a growth-hacking approach to marketing that calls for getting your solution to market as quickly as possible. Once there you iterate quickly and eventually arrive at a good fit (features AND marketing message). A more methodical approach, however, can be equally, if not more effective in healthcare. Proscia invested time and effort to plan their market entry. The result: market acceptance and steady growth. We sat down with Jon Cohen, Head of Corporate Marketing at Proscia to learn more about their go-to-market journey and their keys to success. Learn more about Proscia at https://proscia.com/ Learn more about StudioNorth at https://www.studionorth.com/ Find more great health IT content: https://www.healthcareittoday.com/

In this episode of Startup Hustle, Matt Watson and David West, Co-founder and CEO of Proscia, talk about pathology's shift from microscope to digital. You can learn about the software powering the modern laboratory, the big data generated in the process, and how it can help to improve disease diagnosis and patient outcomes.    Find Startup Hustle Everywhere: https://gigb.co/l/YEh5   This episode is sponsored by Full Scale: https://fullscale.io/   Learn more about Proscia: https://proscia.com/  See omnystudio.com/listener for privacy information.

Oana Olteanu is a Partner @ SignalFire where she focuses on enterprise software at Seed, Series A and Series B. Prior to joining SignalFire, Oana was at Scale Venture Partners where she invested in applied ML and developer tooling. Oana sourced Scale's investments in Observe.ai, Flatfile, and Proscia. She was part of the deal teams for Honeycomb and AllyO (acquired by HireVue). She also supported existing portfolio companies such as Dialpad, Matillion, and BigID. Prior to Scale, Oana was an AI seed investor at SAP.io, SAP's $35M seed fund, where she sourced the investments in Plum.io, Oto.ai, and Akorda. In Today's Episode with Oana Olteanu We Discuss: 1.) From Tank Driving in Romania to VC's Rising Star: How Oana made her way from driving tanks in Romania to becoming a VC? How did leaving Romania for Germany and then moving to the West Coast impact her mindset? What does Oana know now that she wishes she had known when she entered VC? 2.) How to Assess a VC: The Founders Guide: Pre-investment, how can founders know whether a VC can add value? What are the signs? What three core questions will reveal how much value a VC can add? Post-investment, what can founders do to extract the most value from their VCs? What should the founders ask their investors for help with? What should they do themselves? 3.) The VC Founder Relationship: Oana has the highest founder NPS of any VC I have ever had on 20VC, what does Oana believe makes her founders rate her contribution so highly? What works? What does not? How does Oana give sometimes very hard feedback to founders but retain that relationship of trust and safety at the same time? What mistakes do other VCs make in giving feedback? What does Oana believe are the single biggest misalignment between VCs and founders? 4.) VCs Behaving Badly: 101 What are the single biggest ways Oana sees VCs behaving badly? How does Oana think founders expectations of the product of venture should change? Does Oana believe boards are valuable? What can be done to improve them? Items Mentioned in Today's Episode: Oana's Favourite Book: The Daily Stoic: 366 Meditations on Wisdom, Perseverance, and the Art of Living: Featuring new translations of Seneca, Epictetus, and Marcus Aurelius

Sydney Fenkell, Head Of Marketing Communications at Proscia, talks with Jeremy about what content marketing teams can learn from other communications functions.Highlights:How marketers can work with internal comms to develop stronger employee engagementHow internal communicators can help B2B marketers better engage external audiencesStrategies to collaborate with internal comms, HR, and other departmentsLearn more about ProsciaConnect with Sydney on LinkedInMemorable Quotes:"What I've kind of found, just generally working in the comms capacity, is that my role is really to take the great work that our team is doing and get it out there to the world. That's kind of what makes for the most interesting stories. So naturally, I spend a lot of time talking to my colleagues across different areas just so that I have a pulse on what's going on.""The best way to build support for marketing or communications has been to demonstrate the value that it delivers. And once again, I need support from other people to be successful.""Kind of take a step back, consider who you might bring to the table for different initiatives, because you might find that there's some really unique perspectives that come from that."The B2B Content Show is produced by Connversa, a podcast production agency helping B2B brands connecting with prospects, generates TONS of content, and grow revenue. Learn more at connversa.com

One of the biggest pieces of news we've gotten in 2022 is the announcement of new CPT codes from the American Medical Association specifically for digital pathology. What are CPT codes? Why should we care? How will these new codes help us to elevate the practice of anatomic pathology and allow us to more concretely articulate a value proposition for digital pathology? Our guest is Nathan Buchbinder, Chief Product Officer and cofounder at Proscia. We discuss the new CPT codes and much more. We get a current lay of the land for digital pathology in mid-2022. How far have we come in the past five years or so? How far have we come in the past year - which has seen dramatic changes and acceleration in many areas. How do the US and Europe differ in adoption and outlook and what are some continuing barriers to the adoption of digital pathology?

Today my guest is David West, CEO and Cofounder of Proscia What we discuss with David: How he became interested in biomedical engineering and how he discovered pathology Starting Pathology Cloud and how that led to the founding of Proscia The mission of Proscia The Concentriq platform and some of its features How Concentriq can be used in both research and clinical settings The importance of interoperability in digital pathology Some of the partnerships between Proscia and other companies The automated QC feature and how this can save time and money His thoughts on the future of digital pathology Links for this episode: Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   Proscia on Twitter Proscia Website Pathology's Digital Future David West of Proscia: Five Things You Need To Create A Highly Successful Startup   People of Pathology Podcast: Website Twitter

In most hospitals, the practice of radiology went digital years ago. Today you'll rarely find a radiologist examining a broken bone or a fluid-filled lung on a sheet of old-fashioned X-ray film. But pathology isn't as computerized. For a variety of cultural, technical, and regulatory reasons, many pathologists still prefer to look at tissue samples the old-fashioned way, on a slide under a microscope.Philadelpha-based Proscia is working to change that—and open up pathology to the power of remote work and automated image analysis—by building a cloud-based infrastructure for storing and sharing scanned pathology images. Harry's guest today is Proscia CEO David West, who says there are still strong cultural barriers to the adoption of digital pathology, but "the community is realizing this can be really great for them and their discipline." West says easier scanning, higher resolution, faster image delivery, and the ability to review images from anywhere and tap the power of artificial intelligence are powerful advantages driving adoption of Proscia's platform.For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

David West is a computational biologist, entrepreneur, and co-founder of Proscia. Proscia is a company advancing data-driven pathology with its Concentriq platform and computational solutions. He joins BTS to share his journey with Proscia from University spin-off to their recently closed series C funding round. In the second half of the episode, David discusses the challenges and opportunities of working with big data in pathology. Lastly, David shares his insight into how pathologists should go about selecting software tools to meet their needs.

PROGRAMACION JUNIO 16 1. Sisa Feher - Khi - Toulouse 2. Amanda Whiting - Lost in Abstraction - Too Much 3. Julius Rodriguez - Let Sound Tell All - All I Do 4. George Cotsirilos Quartet - Refuge - Let's Make a Break for It 5. Jakob Dinesen Quartet - Unconditional Love - Say 6. Jamie Leeming - Resynthesis - Zen Garden 7. Martín Proscia, Federico Solomiewicz - Rizoma - Doppel 8. Leo Genovese - Ritual - Howaria 9. Mogwai - Boltfor ///////////////////////////////////// CORTINAS Paul McCartney / Junio 18, 1942

It's easy to get caught up in the hype surrounding digital pathology. But what is actually involved and going digital? What are the steps involved? We know about scanners and viewing images, of course. But what other pieces of software might be necessary or helpful? Coleman Stavish is co-founder and CTO at Proscia, a leading provider of digital and computational pathology solutions. At Proscia, Coleman works with a team of engineers and scientists who develop enterprise software in use at leading laboratories and large biopharma companies around the world, as well as novel image classification. We're going to be talking about workflows in digital pathology and the importance of the image management platform. What are the considerations in going digital, how can all of our software work together and how can we truly realize the promise of digital pathology by incorporating AI algorithms and other tools?

Nathan Buchbinder is the founder and Chief Product Officer at Proscia, a company with a mission to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. Learn more about ​​how diagnostic labs and life sciences organizations are using a data-driven approach to pathology with Proscia AI-powered products.

In today's episode, we are joined by Julianna Ianni, vice president of AI research & development at Proscia. In our conversation, Julianna shares her and her team's research focused on developing applications that would help make the life of pathologists easier by enabling tasks to quickly and accurately be diagnosed using deep learning and AI. We also explore their paper “A Pathology Deep Learning System Capable of Triage of Melanoma Specimens Utilizing Dermatopathologist Consensus as Ground Truth”, while talking through how ML aids pathologists in diagnosing Melanoma by building a multitask classifier to distinguish between low-risk and high-risk cases. Finally, we discussed the challenges involved in designing a model that would help in identifying and classifying Melanoma, the results they've achieved, and what the future of this work could look like. The complete show notes for this episode can be found at twimlai.com/go/531.

Fresh from a summer break, Vik and Bree are back with episode thirteen of DrinksWithAVC, featuring a candid chat with Alex Niehenke from Scale Venture Partners. They explore his eclectic passions from pickling to water polo, his experiences as a German immigrant, and the pivotal role of metrics in driving a company's success. Don't miss the sizzling end where Alex predicts which Companies and Firms will extend their 'Hot Girl Summer' glory and which may brace for a chilly season ahead.Links:www.scalevp.comwww.twitter.com/aniehenke www.eatuglypickle.com (Gifts!)

Breakdown: 0:00-14:21 - Intro/Fall Sports Recap 14:21-22:27 - Interview with Girls Swim Coach, Gina Proscia 22:27-End - "World of Sports" College Football Rankings and discussion on NIL

We are talking with David West, CEO of Proscia and Joseph Mossel, CEO of IBEX Medical Analytics. Recently, Proscia, a leading provider of digital and computational pathology solutions, and IBEX Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, announced a strategic partnership to support pathologists in detecting prostate cancer. In this episode, we will learn about the history of these two companies, examine how this partnership will work to help pathologists and patients and where this will lead digital pathology in the future.

Monica Santamaria-Fries is the Digital Transformation Officer at Proscia, a role where she uses her extensive experience as a pathologist to bridge the gap in communicating novel digital pathology technology to the pathology community. Dr. Santamaria-Fries joins the show to discuss her role in digital pathology innovation, the annual digital pathology report generated by Proscia, and why the time is now for digital pathology adoption.3:34 - Introduction and background8:50 - Pathologists bridging the gap when communicating new technologies to other pathologists12:04 - New innovations in computation pathology and improved pathology workflow19:43 - Moments that trigger pathologists to want to go digital27:57 - Highlights of the annual digital pathology report29:11 - Why now is the time to go digital and how to remove roadblocks